Skip to Content

Tactile Systems Technology Inc TCMD

Morningstar Rating
$15.04 +0.47 (3.23%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TCMD is trading at a 49% discount.
Price
$14.72
Fair Value
$83.54
Uncertainty
Very High
1-Star Price
$81.48
5-Star Price
$33.92
Economic Moat
Bfjgy
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TCMD is a good fit for your portfolio.

Trading Information

Previous Close Price
$14.57
Day Range
$14.5515.59
52-Week Range
$9.7026.11
Bid/Ask
$12.66 / $15.52
Market Cap
$357.34 Mil
Volume/Avg
410,885 / 299,479

Key Statistics

Price/Earnings (Normalized)
27.64
Price/Sales
1.27
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
992

Comparables

Valuation

Metric
TCMD
NARI
SIBN
Price/Earnings (Normalized)
27.64410.19
Price/Book Value
1.834.743.66
Price/Sales
1.274.394.22
Price/Cash Flow
16.8365.11
Price/Earnings
TCMD
NARI
SIBN

Financial Strength

Metric
TCMD
NARI
SIBN
Quick Ratio
2.882.438.01
Current Ratio
3.543.099.01
Interest Coverage
−56.99−13.52
Quick Ratio
TCMD
NARI
SIBN

Profitability

Metric
TCMD
NARI
SIBN
Return on Assets (Normalized)
10.70%5.07%−8.97%
Return on Equity (Normalized)
18.16%6.37%−12.61%
Return on Invested Capital (Normalized)
12.90%3.35%−11.78%
Return on Assets
TCMD
NARI
SIBN
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesMhfpqcjrLftxzn$185.5 Bil
SYK
Stryker CorpTdfzzlrrVtyq$128.2 Bil
MDT
Medtronic PLCSlcjhfvbTvxtq$106.7 Bil
BSX
Boston Scientific CorpTgtrgrlcMljjfn$99.0 Bil
DXCM
DexCom IncKbmlyrtnyPphlk$53.1 Bil
EW
Edwards Lifesciences CorpQkgchjltgwBrdfws$52.8 Bil
ZBH
Zimmer Biomet Holdings IncXdzqbbdbFqpvp$24.9 Bil
ALGN
Align Technology IncSfsgbhjyWvcdm$23.5 Bil
PHG
Koninklijke Philips NV ADRDgxgzrkfxJgskjz$18.9 Bil
PODD
Insulet CorpYztwsflwDmmdcj$11.7 Bil

Sponsor Center